Persons with mixed hyperlipidemia are at risk for atherosclerotic cardiovascular disease due to an elevated non–high-density lipoprotein (HDL) cholesterol level, which is driven by remnant cholesterol ...
Two new small interfering RNA (siRNA) therapeutics (both Arrowhead Pharmaceuticals), each targeting different genes involved in the regulation of triglyceride-rich lipoproteins, have been shown to be ...
JUPITER 17,802 Rosuvastatin Black: 2224 (12.4%); Hispanic: 2261 (12.7%); other/unknown: 634 (3.6%) 4S: Scandinavian Simvastatin Survival Study; AFCAPS/TEXCAPS: Air Force/Texas Coronary Atherosclerosis ...
Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...
Hyperlipidemia involves an imbalance of cholesterol levels, including low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) in the blood. LDL-C and HDL-C ...
You call it high cholesterol. Your doctor calls it hyperlipidemia, or dyslipidemia. No matter what name you use, it's a common problem. The term covers several disorders that result in extra fats, ...
Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five years postpartum, according to a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback